|
|
| Continent |
Test |
Subjects |
Positive |
% |
| Europe |
|
1,648 |
1,637 |
99.33 |
 |
| Country |
Test |
Subjects |
Positive |
% |
| Austria |
all |
35 |
33 |
94.29 |
| Belgium |
all |
1 |
1 |
100.00 |
| Bulgaria |
all |
1 |
1 |
100.00 |
| Croatia |
all |
15 |
15 |
100.00 |
| Germany |
all |
12 |
12 |
100.00 |
| Hungary |
all |
26 |
26 |
100.00 |
| Italy |
all |
1,468 |
1,460 |
99.46 |
| Poland |
all |
35 |
34 |
97.14 |
| Romania |
all |
15 |
15 |
100.00 |
| Spain |
all |
19 |
19 |
100.00 |
| Sweden |
all |
16 |
16 |
100.00 |
| Switzerland |
all |
1 |
1 |
100.00 |
| Ukraine |
all |
1 |
1 |
100.00 |
| United Kingdom |
all |
3 |
3 |
100.00 |
Last update of the ReTiME database:
September 30, 2018 01:32 +1GMT
|
|
Loading...
Hom s/Mus m Omalizumab
